CD86 Has Sustained Costimulatory Effects on CD8 T Cells1
暂无分享,去创建一个
L. Wen | F. Wong | R. Flavell | D. Wraith | R. Ravanan | Ian J. Thomas | S. Guerder | L. G. Petrich de Marquesini | Richard M. Smith
[1] G. Freeman,et al. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. , 2007, Immunity.
[2] D. Sansom,et al. Integration of CD28 and CTLA‐4 function results in differential responses of T cells to CD80 and CD86 , 2006, European journal of immunology.
[3] F. Marincola,et al. Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma. , 2005, The Journal of clinical investigation.
[4] L. Wen,et al. The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice. , 2005, Diabetes.
[5] G. Freeman,et al. The B7 family revisited. , 2005, Annual review of immunology.
[6] T. Watts,et al. TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.
[7] L. Orci,et al. A CD8+ T-lymphocyte-mediated and CD4+ T-lymphocyte-independent autoimmune diabetes of early onset in transgenic mice , 1994, Diabetologia.
[8] S. Khoury,et al. The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice , 2003, The Journal of experimental medicine.
[9] Andrea Iaboni,et al. The interaction properties of costimulatory molecules revisited. , 2002, Immunity.
[10] K. Takeda,et al. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. , 2002, International immunology.
[11] C. Thompson,et al. T-cell regulation by CD28 and CTLA-4 , 2001, Nature Reviews Immunology.
[12] J. Gutiérrez-Ramos,et al. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE , 2001, Nature Immunology.
[13] H. Ochs,et al. Induction, binding specificity and function of human ICOS , 2000, European journal of immunology.
[14] G. Freeman,et al. Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells1 , 2000, The Journal of Immunology.
[15] S. Lehar,et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. , 2000, Immunity.
[16] C. Janeway,et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library , 1999, Nature Medicine.
[17] T. Honjo,et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. , 1999, Immunity.
[18] K. Lee,et al. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells. , 1998, Journal of immunology.
[19] R. Flavell,et al. Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes. , 1998, Journal of immunology.
[20] C. Janeway,et al. The Role of Lymphocyte Subsets in Accelerated Diabetes in Nonobese Diabetic–Rat Insulin Promoter–B7-1 (NOD-RIP-B7-1) Mice , 1998, The Journal of experimental medicine.
[21] L. A. Stephens,et al. The threshold for autoimmune T cell killing is influenced by B7‐1 , 1998, European journal of immunology.
[22] B. Kwon,et al. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. , 1997, Journal of immunology.
[23] C. Uyttenhove,et al. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. , 1996, Journal of immunology.
[24] C. Janeway,et al. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells , 1996, The Journal of experimental medicine.
[25] L. A. Stephens,et al. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse. , 1995, International immunology.
[26] R. Flavell,et al. Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. , 1995, Immunity.
[27] C. Janeway,et al. Expression of the Co-stimulator Molecule B7–1 in Pancreatic β-Cells Accelerates Diabetes in the NOD Mouse , 1995, Diabetes.
[28] V. Kouskoff,et al. Cassette vectors directing expression of T cell receptor genes in transgenic mice. , 1995, Journal of immunological methods.
[29] P. Linsley,et al. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. , 1994, Immunity.
[30] Y. Matsuzawa,et al. The NOD mouse. , 1994, Diabetes research and clinical practice.
[31] P. Linsley,et al. CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.
[32] P. Linsley,et al. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function , 1994, The Journal of experimental medicine.
[33] P. Linsley,et al. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[34] R. Flavell,et al. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. , 1994, Immunity.
[35] D. Harlan,et al. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Bluestone,et al. Expression and functional significance of an additional ligand for CTLA-4. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[37] L. Lanier,et al. B70 antigen is a second ligand for CTLA-4 and CD28 , 1993, Nature.
[38] P. Linsley,et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes , 1992, The Journal of experimental medicine.
[39] J. Gribben,et al. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7 , 1991, The Journal of experimental medicine.
[40] A. Monaco,et al. IMMUNOLOGICAL CHARACTERISTICS OF PURIFIED PANCREATIC ISLET GRAFTS , 1986, Transplantation.